HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Cloning and expression of the Bacillus anthracis protective antigen gene in Bacillus subtilis.

Abstract
The gene encoding the protective antigen (PA) moiety of the tripartite exotoxin of Bacillus anthracis was cloned from the recombinant plasmid pSE36 into Bacillus subtilis 1S53 by using the plasmid vector pUB110. Two clones, designated PA1 and PA2, were identified which produced PA in liquid cultures at levels of 20.5 to 41.9 micrograms/ml. This PA was identical to B. anthracis Sterne PA with respect to migration on sodium dodecyl sulfate-polyacrylamide gels and to Western blot antigenic reactivity. Addition of lethal factor or edema factor to PA1 and PA2 supernatants generated biologically active anthrax lethal toxin or edema-producing toxin, respectively. The recombinant plasmid in PA1 (pPA101) was 7.8 kilobases, whereas the PA2 strain plasmid (pPA102) was 6.1 kilobases. Both plasmids had deletions extending into the insert sequence but not into the DNA encoding the PA protein. Immunization with the live recombinant strains protected guinea pigs from lethal challenge with virulent B. anthracis spores, and the immunization partially or completely protected rats from intravenous challenge with anthrax lethal toxin.
AuthorsB E Ivins, S L Welkos
JournalInfection and immunity (Infect Immun) Vol. 54 Issue 2 Pg. 537-42 (Nov 1986) ISSN: 0019-9567 [Print] United States
PMID3021632 (Publication Type: Journal Article)
Chemical References
  • Antigens, Bacterial
  • DNA Restriction Enzymes
Topics
  • Antigens, Bacterial (genetics)
  • Bacillus anthracis (genetics)
  • Bacillus subtilis (genetics)
  • Cloning, Molecular
  • DNA Restriction Enzymes
  • Genes
  • Genes, Bacterial
  • Genetic Vectors
  • Nucleic Acid Hybridization
  • Plasmids
  • Transcription, Genetic
  • Transformation, Bacterial

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: